SCHEMBL8116646

SCHEMBL8116646

O=[N+]([O-])c1ccc2c(c1CO)OC(CO)CO2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TXNRD1 Q16881 1/20 0.40
TXNRD3 Q86VQ6 1/20 0.40
TXNRD2 Q9NNW7 1/20 0.40
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
MAPT P10636 6/20 0.36
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PKM P14618 3/20 0.34
LMNA P02545 3/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HTR1A P08908 1/20 0.31
PRKAB2 O43741 2/20 0.31
PRKAG1 P54619 2/20 0.31
PRKAA2 P54646 2/20 0.31
PRKAA1 Q13131 2/20 0.31
PRKAG3 Q9UGI9 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8125480 0.90 TXNRD1 (0.39) TXNRD1TXNRD3TXNRD2NPC1RAB9A
SCHEMBL10305220 0.90 TXNRD1 (0.39) TXNRD1TXNRD3TXNRD2NPC1RAB9A
SCHEMBL3027768 0.89 MAPT (0.39) TXNRD1TXNRD3TXNRD2NPC1RAB9A
SCHEMBL3029367 0.89 MAPT (0.39) TXNRD1TXNRD3TXNRD2NPC1RAB9A
SCHEMBL13222372 0.87 MAPT (0.44) TXNRD1TXNRD3TXNRD2NPC1RAB9A
SCHEMBL3037529 0.87 TXNRD1 (0.36) TXNRD1TXNRD3TXNRD2NPC1RAB9A
SCHEMBL4361272 0.87 TXNRD1 (0.36) TXNRD1TXNRD3TXNRD2NPC1RAB9A
SCHEMBL3039471 0.87 TXNRD1 (0.36) TXNRD1TXNRD3TXNRD2NPC1RAB9A
SCHEMBL4523570 0.87 TXNRD1 (0.36) TXNRD1TXNRD3TXNRD2NPC1RAB9A
SCHEMBL492529 0.85 TXNRD1 (0.41) TXNRD1TXNRD3TXNRD2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008118935-A1 COMPOUNDS AND PROCESSES FOR PREPARING SUBSTITUTED AMINOMETHYL-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-E]INDOL-8-ONES NEUROGEN CORPORATION (US) 2008-10-02 WO disclosed